A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer

Summary

This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. While the benefits of quitting smoking are numerous, rates of persistent smoking after cancer diagnosis remain high. Research has found that patients who quit smoking but subsequently relapse frequently report the hand/oral habit as a barrier to sustained smoking cessation. The Buckeye Quit Stick is an innovative cessation aid designed to directly address patients' hand/oral habit by substituting the cessation aid for cigarettes without integrating pharmacologic intervention, which is typically managed by their medical provider and may require direct supervision due to the patient's health status. The Buckeye Quit Stick is designed to satisfy the repeated hand/oral pattern or ritual, thereby avoiding the physical loss of holding a cigarette in the hand or mouth and the action of smoking. It may also help occupy fidgeting hands and potentially reduce stress and cravings. This novel cessation resource may address key factors that influence smoking abstinence and improve patients' health outcomes.

Conditions

• Cigarette Smoking-Related Carcinoma
• Malignant Thoracic Neoplasm

Interventions

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Informational Intervention

Receive smoking cessation information

OTHER

Interview

Ancillary studies

OTHER

Referral

Receive referral

DEVICE

Smoking Cessation Intervention

Receive Buckeye Quit Stick

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

• Ohio State University Comprehensive Cancer Center

  lead OTHER

Principal Investigators

• Logan Roof, MD, MS · Ohio State University Comprehensive Cancer Center

Study Design

Allocation

NA

Purpose

PREVENTION

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

21 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2026-02-25

Primary Completion

2027-03-31

Completion

2027-03-31

FDA Device

Yes

Countries

• United States

Study Locations